DD

Deepa Dhiman

Active Director Director DIN 08976841
DIN 08976841 First appointment Nov 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Deepa Dhiman

Data last updated:

Deepa Dhiman is a Director at Kylo Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals.

DIN 08976841
Primary Designation Director
Industry Chemicals
First Appointment 28 Nov 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kylo Pharmaceuticals Private Limited U24230UR2020PTC011814
Director28 Nov 20202020Active

Board colleagues of Deepa Dhiman

NameDINCompanyDesignation
Anurag Sharma08976840Kylo Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kylo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Deepa Dhiman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepa Dhiman

Deepa Dhiman currently holds 1 directorship: Kylo Pharmaceuticals Private Limited (Director, since 28 Nov 2020).

Deepa Dhiman was first appointed on 28 Nov 2020 as Director at Kylo Pharmaceuticals Private Limited.

The current boards of Deepa Dhiman's companies include Anurag Sharma (Kylo Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available